These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

978 related items for PubMed ID: 27779717

  • 1. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W, Chen Y, Gong Y, Dong T, Zhang B, Gao W.
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [Abstract] [Full Text] [Related]

  • 2. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P, Su Z, Zhang Z, Gao T.
    Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
    [Abstract] [Full Text] [Related]

  • 3. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI, Kim DK, Seo EJ, Choi EJ, Kwon YW, Jang IH, Lee JC, Kim HY, Shong M, Kim JH, Kim SJ.
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [Abstract] [Full Text] [Related]

  • 4. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
    Wang XM, Liu Y, Fan YX, Liu Z, Yuan QL, Jia M, Geng ZS, Gu L, Lu XB.
    Cancer Biol Ther; 2018 Jul 03; 19(7):590-597. PubMed ID: 29561707
    [Abstract] [Full Text] [Related]

  • 5. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L, Xi J, Xu X, Peng B, Zhang B.
    Biomed Pharmacother; 2019 Jan 03; 109():902-909. PubMed ID: 30551544
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells.
    Li W, Reeb AN, Sewell WA, Elhomsy G, Lin RY.
    PLoS One; 2013 Jan 03; 8(5):e65095. PubMed ID: 23724124
    [Abstract] [Full Text] [Related]

  • 7. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
    Haghpanah V, Fallah P, Tavakoli R, Naderi M, Samimi H, Soleimani M, Larijani B.
    Tumour Biol; 2016 Jan 03; 37(1):1299-308. PubMed ID: 26289851
    [Abstract] [Full Text] [Related]

  • 8. Diallyl trisulphide, a H2 S donor, compromises the stem cell phenotype and restores thyroid-specific gene expression in anaplastic thyroid carcinoma cells by targeting AKT-SOX2 axis.
    Zhang L, Xu S, Cheng X, Zheng J, Wang Y, Wu J, Wang X, Wu L, Yu H, Bao J.
    Phytother Res; 2021 Jun 03; 35(6):3428-3443. PubMed ID: 33751676
    [Abstract] [Full Text] [Related]

  • 9. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma.
    Bozorg-Ghalati F, Hedayati M, Dianatpour M, Mosaffa N, Azizi F.
    Asian Pac J Cancer Prev; 2019 May 25; 20(5):1353-1360. PubMed ID: 31127889
    [Abstract] [Full Text] [Related]

  • 10. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
    Yang B, Lu Y, Zhang A, Zhou A, Zhang L, Zhang L, Gao L, Zang Y, Tang X, Sun L.
    PLoS One; 2015 May 25; 10(6):e0129138. PubMed ID: 26111245
    [Abstract] [Full Text] [Related]

  • 11. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
    Zhang L, Zhang J, Li S, Zhang Y, Liu Y, Dong J, Zhao W, Yu B, Wang H, Liu J.
    RNA Biol; 2021 Apr 25; 18(4):547-562. PubMed ID: 32951513
    [Abstract] [Full Text] [Related]

  • 12. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C, Conzatti K, Baldan F, Allegri L, Sponziello M, Rosignolo F, Russo D, Filetti S, Damante G.
    Oncol Rep; 2018 Feb 25; 39(2):582-588. PubMed ID: 29251329
    [Abstract] [Full Text] [Related]

  • 13. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, Li Z, Shen M, Kebebew E.
    Oncotarget; 2015 Jul 20; 6(20):18038-49. PubMed ID: 25945839
    [Abstract] [Full Text] [Related]

  • 14. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
    Heiden KB, Williamson AJ, Doscas ME, Ye J, Wang Y, Liu D, Xing M, Prinz RA, Xu X.
    J Clin Endocrinol Metab; 2014 Nov 20; 99(11):E2178-87. PubMed ID: 25078145
    [Abstract] [Full Text] [Related]

  • 15. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
    Fuziwara CS, Saito KC, Kimura ET.
    Thyroid; 2020 Jan 20; 30(1):81-94. PubMed ID: 31578932
    [Abstract] [Full Text] [Related]

  • 16. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma.
    Xu T, Zhu C, Chen J, Song F, Ren X, Wang S, Yi X, Zhang Y, Zhang W, Hu Q, Qin H, Liu Y, Zhang S, Tan Z, Pan Z, Huang P, Ge M.
    J Exp Clin Cancer Res; 2023 Jul 27; 42(1):182. PubMed ID: 37501099
    [Abstract] [Full Text] [Related]

  • 17. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
    Shiraiwa K, Matsuse M, Nakazawa Y, Ogi T, Suzuki K, Saenko V, Xu S, Umezawa K, Yamashita S, Tsukamoto K, Mitsutake N.
    Thyroid; 2019 May 27; 29(5):674-682. PubMed ID: 30784360
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X, Liu L, Deng X, Li D, Cai H, Ma Y, Jia C, Wu B, Fan Y, Lv Z.
    Oncogene; 2019 Jan 27; 38(5):699-715. PubMed ID: 30171257
    [Abstract] [Full Text] [Related]

  • 19. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y, Hua Y, Li Y, Zhang C, Yu W, Guo P, Zou K, Li W, Sun Y, Wang R, Zuo Y, Sui S, Tian C, Hao J, Chen M, Hu S, Chen M, Long Q, Wang X, Zou L, Xie F, Guo W, Deng W.
    Cell Death Differ; 2021 Apr 27; 28(4):1347-1363. PubMed ID: 33162555
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA, Cengiz H, Ates H, Kocdor H.
    Anticancer Agents Med Chem; 2019 Apr 27; 19(15):1887-1898. PubMed ID: 31584382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.